We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 26 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. 関東化学株式会社 Tokyo//Chemical バイオケミカル部
  3. null/null
  4. 4 キャタレント・ジャパン Tokyo//Manufacturing and processing contract
  5. 5 カツマタ Shizuoka//Medical and Welfare 医薬品製造販売部
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  2. Development of various types of medium-sized molecule (nucleic acid, peptide) pharmaceuticals (processes, analytical methods, etc.)
  3. Global Procurement of Reference Drugs <From Drug Procurement to Problem Solving> キャタレント・ジャパン
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. 4 Pharmaceutical CDMO services 大塚化学

medicine Product List

121～135 item / All 517 items

Displayed results
[Research Material] The Global Market for Alopecia Treatment

[Research Material] The Global Market for Alopecia Treatment

Global Market for Alopecia Treatment: Topical Medications, Oral Medications, Injectables, Hair Transplant Services, Others, Hospitals, Dermatology and Hair Clinics, Home Healthcare Facilities, Others

This research report (Global Alopecia Treatment Market) investigates and analyzes the current state and outlook for the global market for alopecia treatment over the next five years. It includes information on the overview of the global alopecia treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the alopecia treatment market include topical agents, oral medications, injectables, hair transplant services, and others, while the segments by application cover hospitals, dermatology and hair clinics, home healthcare facilities, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for alopecia treatment. It also includes the market share of major companies in alopecia treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Swine Respiratory Disease Treatment

[Research Material] The Global Market for Swine Respiratory Disease Treatment

Global Market for Swine Respiratory Disease Treatment: Viruses, Bacteria, Mycoplasma, Parasites, Others, Pharmacies, Veterinary Hospitals, Clinics, Others

This research report (Global Swine Respiratory Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for swine respiratory disease treatment over the next five years. It includes information on the overview of the global swine respiratory disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the swine respiratory disease treatment market target viruses, bacteria, mycoplasma, parasites, and others, while the segments by application focus on pharmacies, veterinary hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for swine respiratory disease treatment. It also includes the market share of major companies in swine respiratory disease treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
【Research Material】Global Market for Lysosomal Storage Disorder (LSD) Treatments

【Research Material】Global Market for Lysosomal Storage Disorder (LSD) Treatments

Global Market for Lysosomal Storage Disorder (LSD) Treatments: Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy, Others, Hospitals, Clinics, Others

This research report (Global Lysosomal Storage Diseases Therapeutics Mar) investigates and analyzes the current state and outlook for the global market of lysosomal storage disease (LSD) therapeutics over the next five years. It includes information on the global overview of the lysosomal storage disease (LSD) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for lysosomal storage disease (LSD) therapeutics by type include enzyme replacement therapy, stem cell therapy, substrate reduction therapy, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for lysosomal storage disease (LSD) therapeutics. It also includes the market share of major companies in lysosomal storage disease (LSD) therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Duchenne Muscular Dystrophy Treatment

[Research Material] The Global Market for Duchenne Muscular Dystrophy Treatment

World Market for Duchenne Muscular Dystrophy Treatment: Analgesics, Corticosteroids, Prednisolone, Prednisone, Deflazacort, ...

This research report (Global Duchenne Muscular Dystrophy Therapeutics Market) investigates and analyzes the current state and outlook for the global market for Duchenne muscular dystrophy treatments over the next five years. It includes information on the overview of the global Duchenne muscular dystrophy treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for Duchenne muscular dystrophy treatments by type include analgesics, corticosteroids, prednisolone, prednisone, and deflazacort, while the segments by application focus on hospitals, clinics, and home healthcare. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Duchenne muscular dystrophy treatments. It also includes the market share of major companies in Duchenne muscular dystrophy treatments, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Chronic Idiopathic Constipation (CIC)

[Research Material] Global Market for Treatment of Chronic Idiopathic Constipation (CIC)

World Market for Chronic Idiopathic Constipation (CIC) Treatments: Lubiprostone, Linaclotide, Others, Hospitals & Clinics, Outpatient Surgical Centers, Long-term Care...

This research report (Global Chronic Idiopathic Constipation (CIC) Drugs Market) investigates and analyzes the current status and future outlook of the global market for chronic idiopathic constipation (CIC) treatment drugs over the next five years. It includes information on the overview of the global chronic idiopathic constipation (CIC) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for chronic idiopathic constipation (CIC) treatment drugs by type include lubiprostone, linaclotide, and others, while the segments by application focus on hospitals/clinics, outpatient surgical centers, nursing centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for chronic idiopathic constipation (CIC) treatment drugs. It also includes the market share of major companies in the chronic idiopathic constipation (CIC) treatment drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Chronic Lymphocytic Leukemia (CLL) Treatment Drugs

[Research Material] Global Market for Chronic Lymphocytic Leukemia (CLL) Treatment Drugs

World Market for Chronic Lymphocytic Leukemia (CLL) Treatments: Injectable, Oral, Hospitals, Clinics

This research report (Global Chronic Lymphocytic Leukemia Therapeutics M) investigates and analyzes the current status and outlook for the global market of chronic lymphocytic leukemia (CLL) therapeutics over the next five years. It includes information on the overview of the global CLL therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for CLL therapeutics focus on injectable and oral forms, while the segments by application target hospitals and clinics. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for CLL therapeutics. It also includes the market share of major companies in the CLL therapeutics sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Atrophic Gastritis Treatment

[Research Material] The Global Market for Atrophic Gastritis Treatment

Global Market for Atrophic Gastritis Treatment: Coatings, Antibiotics, Vitamin B-12, Hospital Pharmacies, Retail Pharmacies, Drugstores, Online Pharmacies

This research report (Global Atrophic Gastritis Treatment Market) investigates and analyzes the current state and outlook for the global market for atrophic gastritis treatment over the next five years. It includes information on the overview of the global atrophic gastritis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the atrophic gastritis treatment market focus on coating agents, antibiotics, and vitamin B-12, while the segments by application target hospital pharmacies, retail pharmacies, drugstores, and online pharmacies. The regional segments calculate the market size for atrophic gastritis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in atrophic gastritis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Castleman Disease Treatment

[Research Material] The Global Market for Castleman Disease Treatment

Global Market for Castleman Disease Treatment: Monoclonal Antibodies, Chemotherapy, Radiation Therapy, Immunotherapy, Corticosteroids, Antiviral Drugs, Disease ...

This research report (Global Castleman Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for Castleman disease treatment over the next five years. It includes information on the overview of the global Castleman disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Castleman disease treatment market include monoclonal antibodies, chemotherapy, radiation therapy, immunotherapy, corticosteroids, and antiviral drugs, while the segments by application focus on hospitals, clinics, and outpatient units. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Castleman disease treatment. It also includes the market share of major companies in Castleman disease treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Antifungal Drugs for Dermatophyte Nail Infections (DOT)

[Research Material] Global Market for Antifungal Drugs for Dermatophyte Nail Infections (DOT)

World Market for Antifungal Drugs for Dermatophyte Nail Infections: Topical, Oral Therapy, Hospitals, Dermatology and Podiatry Clinics, Independent Pharmacies, Mail-Order Pharmacies, Drugstores

This research report (Global Dermatophytic Onychomycosis Therapeutics (D)) investigates and analyzes the current status and outlook for the global market of dermatophytic onychomycosis therapeutics (DOT) over the next five years. It includes information on the overview of the global dermatophytic onychomycosis therapeutics (DOT) market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for dermatophytic onychomycosis therapeutics (DOT) by type focus on topical and oral therapies, while the segments by application target hospitals, dermatology and podiatry clinics, independent pharmacies, mail-order pharmacies, and drugstores. The regional segments calculate the market size of dermatophytic onychomycosis therapeutics (DOT) by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in dermatophytic onychomycosis therapeutics (DOT), product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Gaucher Disease (GD) Treatments

[Research Material] Global Market for Gaucher Disease (GD) Treatments

Global Market for Gaucher Disease (GD) Treatments: Enzyme Replacement Therapy, Substrate Reduction Therapy, Non-Neuropathic Gaucher Disease, Neuropathic Gaucher Disease

This research report (Global Gaucher Disease (GD) Drugs Market) investigates and analyzes the current status and future outlook of the global market for Gaucher disease (GD) treatment drugs over the next five years. It includes information on the overview of the global Gaucher disease (GD) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for Gaucher disease (GD) treatment drugs by type include enzyme replacement therapy and substrate reduction therapy, while the segments by application focus on non-neuropathic Gaucher disease and neuropathic Gaucher disease. The regional segments calculate the market size for Gaucher disease (GD) treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the Gaucher disease (GD) treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment

Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment

Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment: Off-Label, Therapeutics, Hospital Pharmacies, Online Providers, Retail Pharmacies

This research report (Global Non-Alcoholic Steatohepatitis (NASH) Treatment) investigates and analyzes the current status and outlook for the global market for non-alcoholic steatohepatitis (NASH) treatment over the next five years. It includes information on the overview of the global non-alcoholic steatohepatitis (NASH) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for non-alcoholic steatohepatitis (NASH) treatment by type focus on off-label and therapeutic drugs, while the segments by application target hospital pharmacies, online providers, and retail pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for non-alcoholic steatohepatitis (NASH) treatment. It also includes the market share of major companies in non-alcoholic steatohepatitis (NASH) treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Point-of-Care Diagnostic Tests

[Market Report] Global Market for Point-of-Care Diagnostic Tests

With the rapid increase in demand for swift and accurate testing, the global market for POC (point-of-care) diagnostic tests is experiencing rapid growth.

The global POC market is experiencing unprecedented growth due to the increasing demand for rapid and accurate testing solutions. Point-of-care diagnostic tests, also known as bedside testing or near-patient testing, enable timely decision-making by healthcare professionals and improve patient outcomes through rapid diagnosis and treatment. As the value of rapid and accurate testing is recognized by healthcare institutions worldwide in enhancing patient care and streamlining healthcare delivery, the global POC market is poised for continued growth. Please check the application method from the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Organ Transplant Rejection Treatment Drug Market

[Market Report] Global Organ Transplant Rejection Treatment Drug Market

The global market for organ transplant rejection treatment drugs is rapidly expanding and is expected to reach 7 billion USD by 2031.

The global organ transplant rejection treatment drug market recorded a market size of 4.9 billion USD in 2022 and is expected to see significant expansion. It is projected to grow at a compound annual growth rate (CAGR) of 3.9% during the forecast period from 2023 to 2031, reaching an estimated value of 7 billion USD by 2031. The driving forces behind this growth are the increase in organ transplant surgeries and advancements in immunosuppressive therapies. The growth of the global organ transplant rejection treatment drug market plays a crucial role in enhancing the quality of life for transplant recipients. Continuous technological innovations and advancements will make this market extremely important in ensuring the success of organ transplant surgeries worldwide. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Neuropathic Pain Medications

[Market Report] Global Market for Neuropathic Pain Medications

The global market for neuropathic pain treatment drugs is expected to rapidly expand to $10.4 billion by 2031, alleviating suffering worldwide.

The global market for neuropathic pain medications is specialized in improving the lives of people suffering from neuropathic pain and has made significant progress. In 2022, this important market generated approximately $5.8 billion in revenue. It is projected to reach an estimated $10.4 billion by 2031, showing a stable compound annual growth rate (CAGR) of 5% during the forecast period from 2023 to 2031. Neuropathic pain is characterized by sharp, stabbing pain and burning sensations, often caused by nerve damage or dysfunction. Neuropathic pain is a complex condition that significantly impacts the quality of life for millions of people worldwide. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Psoriasis Treatments

[Market Report] Global Market for Psoriasis Treatments

The global market for psoriasis treatments is expected to rapidly expand, reaching 55.72 billion USD by 2031.

The global market for psoriasis treatments has experienced significant growth and plays a crucial role in addressing this challenging skin condition. In 2022, the market size reached 25.2 billion USD and is projected to reach 55.72 billion USD by 2031. This notable increase indicates a steady compound annual growth rate (CAGR) of 9.3% during the forecast period from 2023 to 2031. Psoriasis is a chronic skin disease affecting millions of people worldwide, characterized by red, itchy, scaly patches on the skin's surface. The increasing prevalence of psoriasis, heightened awareness, and advancements in treatment options are driving the expansion of the psoriasis treatment market. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.